ctDNA Testing

Concepts

• trafford
• laboratory reagents
• commission ctdna testing
• ctdna testing
• ctdna
• testing
• chemical reagents
• non-small cell lung cancer
• genomic medicine
• 5th floor

Location

Trafford

Description

Invitation to tender for Circulating tumour DNA (ctDNA) next generation sequencing (NGS) assay.

Total Quantity or Scope

Manchester University NHS Foundation Trust (MFT) has a requirement for ctDNA testing of non-small cell lung cancer, at St Mary’s Hospital, Genomic Medicine. MFT are requiring a ctDNA Next Generation Sequencing (NGS) assay which can detect non-small cell lung cancer. MFT has been indicated by NHS England (NHSE) that it will act as a centre to commission ctDNA testing following an application to NHSE. MFT are looking to establish a high throughput service for the North West Genomic Laboratory Hub (GLH), working on behalf of the national network.The contract will be a 5 year initial term with an option to extend for an additional 2 years in 1 year instalments. The first year of the contract will be a bridging service to the awarded supplier. The testing will then be provided within St Mary's Hospital, 5th Floor for the remaining duration of the contract.

Renewal Options

1year + 1year

CPV Codes

• 33696500 - Laboratory reagents
• 33696300 - Chemical reagents

Indicators

• Bids should cover the whole contract.
• Renewals are available.
• Award on basis of price and quality.